feedback welcome

Fluvoxamine-maprotiline

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
Line 3: Line 3:
| to = maprotiline
| to = maprotiline
| stop =  
| stop =  
-
* '''Before day 1:''' gradually reduce dosage of fluvoxamine to a maximum of 50 mg/ day when this dosage is > 50 mg/day.
+
{{stopFluvoxamine}}
-
* '''Day 1:''' reduce dosage of fluvoxamine to a maximum of 25 mg/day.
+
| start =  
| start =  
* '''Day 1:''' simultaneously start administration of maprotiline in a low dosage of 25-75 mg/day.
* '''Day 1:''' simultaneously start administration of maprotiline in a low dosage of 25-75 mg/day.
Line 12: Line 11:
* "Start low, go slow" is not required, but caution is necessary.
* "Start low, go slow" is not required, but caution is necessary.
* {{theorSS}}
* {{theorSS}}
-
{{review}}
 
}}
}}

Current revision as of 13:04, 28 October 2015

Fluvoxamine
Type Antidepressant
Group SSRI
links
Medscape Fluvoxamine
PubChem 5324346
PubMed Fluvoxamine
Kompas (Dutch) Fluvoxamine
Wikipedia Fluvoxamine
Maprotiline
Type Antidepressant
Group NRI
links
Medscape Maprotiline
PubChem 4011
PubMed Maprotiline
Kompas (Dutch) Maprotiline
Wikipedia Maprotiline

Switch medication from fluvoxamine to maprotiline.

Nietinrijdenbord.png Stop fluvoxamine
Eenrichtingbord.png Start maprotiline
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About